Meiwei Biology-B (02493): Huajun appointed as authorized representative.

22:02 18/06/2026

Miway Biotech-B (02493) announces that as of June 18, 2026, Mr. Hu Huiguo will no longer hold the position of authorized representative under Rule 3.05 of the Securities Listing Rules of the Stock Exchange of Hong Kong for the company; and Mr. Hua Jun has been appointed as the authorized representative of the company. After the appointment of Mr. Hua Jun, the authorized representatives of the company are Mr. Hua Jun and Ms. Liang Junhui.

Merry Biotech-B (02493) announced that, starting from June 18, 2026, Mr. Hu Huiguo will no longer serve as the authorized representative of the company under Rule 3.05 of the Listing Rules of The Stock Exchange of Hong Kong Limited, and Mr. Hua Jun has been appointed as the authorized representative of the company. After the appointment of Mr. Hua Jun, the authorized representatives of the company are Mr. Hua Jun and Ms. Liang Junhui.

CENTRALCHINA MT(09982) plans to issue 773 million shares of subscription shares.

DELTON (01989) will distribute a final dividend of HKD 6.46 per 10 shares on July 16th.

DAISHOMICROLINE (00567) announced its annual performance with a loss of 21.27 million Hong Kong dollars in the year, representing a year-on-year growth of 0.69%.

CENTRALCHINA MT(09982) plans to issue 773 million shares of subscription shares.

DELTON (01989) will distribute a final dividend of HKD 6.46 per 10 shares on July 16th.

DAISHOMICROLINE (00567) announced its annual performance with a loss of 21.27 million Hong Kong dollars in the year, representing a year-on-year growth of 0.69%.